Statement for appropriate clinical use of PCSK9 inhibitors

Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors

doi:10.5551/jat.45229

Statement for appropriate clinical use of PCSK9 inhibitors

Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors

School of Medicine

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Original language	English
Pages (from-to)	747-750
Number of pages	4
Journal	Journal of Atherosclerosis and Thrombosis
Volume	25
Issue number	8
DOIs	https://doi.org/10.5551/jat.45229
State	Published - 2018

Keywords

Appropriate clinical use
PCSK9 inhibitors
Statement

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5551/jat.45229

Cite this

@article{c296d3d6deb04fd5b37a993a05d438f2,

title = "Statement for appropriate clinical use of PCSK9 inhibitors",

keywords = "Appropriate clinical use, PCSK9 inhibitors, Statement",

author = "{Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors} and Atsushi Nohara and Hirotoshi Ohmura and Hiroaki Okazaki and Masatsune Ogura and Kazuo Kitagawa and Masahiro Koseki and Kayoko Sato and Kazuhisa Tsukamoto and Shizuya Yamashita",

year = "2018",

doi = "10.5551/jat.45229",

language = "英語",

volume = "25",

pages = "747--750",

journal = "Journal of Atherosclerosis and Thrombosis",

issn = "1340-3478",

publisher = "Japan Atherosclerosis Society",

number = "8",

}

TY - JOUR

T1 - Statement for appropriate clinical use of PCSK9 inhibitors

AU - Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors

AU - Nohara, Atsushi

AU - Ohmura, Hirotoshi

AU - Okazaki, Hiroaki

AU - Ogura, Masatsune

AU - Kitagawa, Kazuo

AU - Koseki, Masahiro

AU - Sato, Kayoko

AU - Tsukamoto, Kazuhisa

AU - Yamashita, Shizuya

PY - 2018

Y1 - 2018

KW - Appropriate clinical use

KW - PCSK9 inhibitors

KW - Statement

UR - http://www.scopus.com/inward/record.url?scp=85051117491&partnerID=8YFLogxK

U2 - 10.5551/jat.45229

DO - 10.5551/jat.45229

M3 - コメント/討論

C2 - 29899173

AN - SCOPUS:85051117491

SN - 1340-3478

VL - 25

SP - 747

EP - 750

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

IS - 8

ER -

Statement for appropriate clinical use of PCSK9 inhibitors

Keywords

UN SDGs

Access to Document

Other files and links

Cite this